Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.

Gregory Lip, LH Rasmussen, SB Olsson, S Zetterstrand, C Stahre, A Bylock, M Aunes-Jansson, U Eriksson, K Wåhlander

Research output: Contribution to journalArticle

31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.'. Together they form a unique fingerprint.

Medicine & Life Sciences